Skip to main content
. 2020 May 15;9(19):6923–6932. doi: 10.1002/cam4.3120

Table 3.

Safety Profile

Toxicity LTSs Nivolumab treatment duration
(N = 65)

<2 y

(n = 47)

2 y

(n = 7)

>2 y

(n = 11)

Any grade 44 (67.7) 30 (63.8) 6 (85.7) 8 (72.7)
Grade > 2 17 (26.2) 16 (34.0) 0 (0) 1 (9.1)

Results are expressed as n (%).

Abbreviations: LTSs, long‐term survivors.